Candel Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $855k | 541k | 1.58 |
| 2023-12-31 | $626k | 426k | 1.47 |
| 2023-09-30 | $372k | 404k | 0.92 |
| 2023-06-30 | $511k | 406k | 1.26 |
| 2023-03-31 | $548k | 406k | 1.35 |
| 2022-12-31 | $726k | 406k | 1.79 |
| 2022-06-30 | $1.3M | 406k | 3.24 |
| 2022-03-31 | $2.1M | 407k | 5.09 |
| 2021-09-30 | $2.3M | 214k | 10.84 |